摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4-氯苯基)-3-氧代丁腈 | 5219-07-8

中文名称
2-(4-氯苯基)-3-氧代丁腈
中文别名
2-(2-呋喃)-1H-苯并咪唑-5-羧酸
英文名称
2-(4-chlorophenyl)-3-oxobutanenitrile
英文别名
——
2-(4-氯苯基)-3-氧代丁腈化学式
CAS
5219-07-8
化学式
C10H8ClNO
mdl
MFCD01672899
分子量
193.633
InChiKey
IPBZEJZUAZXNOS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    13
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    40.9
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2926909090

SDS

SDS:6232a0e358234d0d5f6e737d7057f519
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-(4-Chlorophenyl)-3-oxobutanenitrile
Synonyms: alfa-Acetyl-p-chloropheny1acetonitrile

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-(4-Chlorophenyl)-3-oxobutanenitrile
CAS number: 5219-07-8

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H8ClNO
Molecular weight: 193.6

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK
    申请人:McCall John M.
    公开号:US20120277224A1
    公开(公告)日:2012-11-01
    Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.
    本文披露了新的杂环化合物和组合物,以及它们作为药物治疗疾病的应用。还提供了抑制PAS激酶(PASK)在人类或动物主体中活性的方法,用于治疗疾病,如糖尿病。
  • Oxidative aromatic C–N bond formation: convenient synthesis of N-amino-3-nitrile-indoles via FeBr3-mediated intramolecular cyclization
    作者:Zisheng Zheng、Lina Tang、Yanfeng Fan、Xiuxiang Qi、Yunfei Du、Daisy Zhang-Negrerie
    DOI:10.1039/c1ob05069a
    日期:——
    functionalized N-amino-3-nitrile-indole derivatives are obtained via an intramolecular hetero-cyclization of 2-aryl-3-substituted hydrazono-alkylnitriles using FeBr3 as a single electron oxidant. This approach allows the N-moiety on the side-chain to be annulated to the benzene ring during the final synthetic step via direct oxidative aromatic C–N bond formation.
    通过使用FeBr 3作为单电子氧化剂,通过2-芳基-3-取代的肼基-烷基腈的分子内杂环化,可获得各种官能化的N-氨基-3-腈-吲哚衍生物。这种方法允许在最后的合成步骤中,通过直接氧化芳族C–N键的形成,将侧链上的N部分环合到苯环上。
  • Quantitative relations between structure and activation of fibrinolysis in selected series of arylaliphatic acids
    作者:Miroslav Kuchař、Bohumila Brunová、Václav Rejholc、Magda Jelínková、Jiří Holubek、Oldřich Němeček
    DOI:10.1135/cccc19840122
    日期:——

    The paper describes the reaction of arylacetones IX with triethyl phosphonoacetate, producing esters of 4-aryl-3-methyl-2-butenoic acid, X, and 4-aryl-3-methyl-3-butenoic acid, X'. Their hydrolysis gave a mixture of the isomeric acids I and I', whose composition was investigated by 1H NMR spectra. Also prepared were 3-methyl-3-phenyl-2-propenoic acids, II, 2-aryl-2-hydroxypropanoic acids, IV, and substituted α-benzyloxyphenylacetic acids, V. These acids, along with aryloxoaliphatic acids III, were investigated for efficacy in activation of fibrinolysis. The lipophilicites of the acids studied were determined either through the partition coefficients (acids Ia and IIa), using a system n-octanol-water (pH 3.5) or by partition chromatography. The experimental values of log Pwere compared with those calculated from the fragmental constants f and the parameters π. With the acids V the decrease in lipophilicity was similar to that observed with arylalkoxyaliphatic acids. With the acids, I, I' and II the fibrinolytic capacity was linearly proportional to lipophilicity. Although we evaluated fibrinolytic capacity of mixtures of the acids I and I', the linear relation was in agreement with that derived previously for a group of arylaliphatic acids. The presence of a functional group on the connecting chain in the acids III and IV had a negative effect on the fibrinolytic capacity. The decrease in fibrinolytic capacity might be due the functional groups being capable of forming hydrogen bonds.

    这篇论文描述了芳基醋酮IX与三乙基磷酸乙酯反应,生成4-芳基-3-甲基-2-丁烯酸酯X和4-芳基-3-甲基-3-丁烯酸酯X'。它们的水解产生了异构酸II'的混合物,其组成通过1H NMR谱进行了研究。还制备了3-甲基-3-苯基-2-丙烯酸II,2-芳基-2-羟基丙酸IV和取代的α-苄氧基苯乙酸V。这些酸,连同芳基氧代脂肪酸III,被研究其在激活纤溶作用中的功效。所研究的酸的亲脂性通过分配系数(酸IaIIa)或通过分配色谱法在正辛醇-水(pH 3.5)体系中确定。实验值log P与从片段常数f和参数π计算得到的值进行了比较。对于酸V,亲脂性的降低类似于观察到的芳基氧代脂肪酸。对于酸I, I'II,纤溶能力与亲脂性成正比。尽管我们评估了酸II'的混合物的纤溶能力,但线性关系与先前得出的一组芳基脂肪酸的结果一致。酸IIIIV中连接链上的功能基团对纤溶能力有负面影响。纤溶能力的降低可能是由于功能基团能够形成氢键。
  • [EN] IMINOTETRAHYDROPYRIMIDINONE DERIVATIVES AS PLASMEPSIN V INHIBITORS<br/>[FR] DÉRIVÉS D'IMINOTÉTRAHYDROPYRIMIDINONE UTILISÉS COMME INHIBITEURS DE PLASMEPSINE V
    申请人:UCB BIOPHARMA SPRL
    公开号:WO2017089453A1
    公开(公告)日:2017-06-01
    A series of 2-imino-6-methyltetrahydropyrimidin-4(lH)-one derivatives, substituted in the 6-position by a phenyl moiety which in turn is meta-substituted by an optionally substituted unsaturated fused bicyclic ring system containing at least one nitrogen atom, being selective inhibitors of plasmepsin V activity, are beneficial as pharmaceutical agents, especially in the treatment of malaria.
    一系列在6-位置被苯基取代的2-亚氨基-6-甲基四氢嘧啶-4(1H)-酮衍生物,该苯基再通过一个可选取代的不饱和融合双环环系统进行间位取代,该环系统含有至少一个氮原子,作为血液型质体蛋白酶V活性的选择性抑制剂,对于药物制剂特别有益,尤其在治疗疟疾方面。
  • An expeditious method to synthesize difluoroboron complexes of β-keto amides from β-keto nitriles and BF<sub>3</sub>·OEt<sub>2</sub>
    作者:Chuangchuang Xu、Jiaxi Xu
    DOI:10.1039/c7ob01356f
    日期:——
    synthesize difluoroboron complexes of β-keto amides has been developed from β-keto nitriles and BF3·OEt2. BF3·OEt2 serves as both a BF2 source and a Lewis acid catalyst in the synthetic strategy. The formation mechanism of the difluoroboron complexes from β-keto nitriles and BF3·OEt2 was proposed. The difluoroboron complexes can be further converted into β-keto amides by treatment with sodium acetate
    从β-酮腈和BF 3 ·OEt 2出发,开发了一种便捷的合成β-酮酰胺的二氟硼配合物的策略。在合成策略中,BF 3 ·OEt 2既是BF 2的来源又是路易斯酸的催化剂。β-酮腈与BF 3 ·OEt 2形成二氟硼配合物的机理被提出。通过用乙酸钠处理,二氟硼配合物可以进一步转化为β-酮酰胺。该策略的优点是具有广泛的底物范围,非金属催化作用和易于操作等优点。一些二氟硼配合物在固态中显示出良好的荧光特性,并在固态发光材料中具有潜在的应用前景。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐